These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 2441642)

  • 1. [Pharmacologic study of nicergoline in the pathology of the cervico-prostatic sphincter].
    Ghaddar Y; Caissel J; Léandri P; Rossignol G
    Ann Urol (Paris); 1987; 21(2):107-14. PubMed ID: 2441642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Results of the double-blind use of an alpha blockader, nicergoline, in cervico-prostatic dysfunctions].
    Colombeau P; Ballanger P
    J Urol (Paris); 1987; 93(9-10):533-5. PubMed ID: 3327892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effects of nicergoline on artificially induced micturition in the rabbit with and without prostatic hypertrophy].
    Richard O; Weber J; Moore N; Boismare F
    J Pharmacol; 1986; 17(4):664-70. PubMed ID: 2436010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Symptomatic treatment of benign prostatic obstruction with nicergoline: a placebo controlled clinical study and urodynamic evaluation.
    Ronchi F; Margonato A; Ceccardi R; Rigatti P; Rossini BM
    Urol Res; 1982; 10(3):131-4. PubMed ID: 6182672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The importance and significance of post-micturitional bladder residue in the evaluation of prostatism].
    Leblanc G; Tessier J; Schick E
    Prog Urol; 1995 Sep; 5(4):511-4. PubMed ID: 7581500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Use of electromyography of the bladder sphincter for the differentiation of prostate adenoma and prostate carcinoma].
    Steinhauser I
    Z Urol Nephrol; 1979 Mar; 72(3):171-3. PubMed ID: 88850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro effect of nicergoline on the contractility of human bladder neck.
    Grasso M; Ronchi F; Lania C; Di Girolamo V; Hadjigeorgiou D; Annoni F; Mantovani G; Margonato A
    Farmaco Prat; 1983 Dec; 37(12):408-10. PubMed ID: 6822287
    [No Abstract]   [Full Text] [Related]  

  • 8. BPH treatment: urodynamic preoperative assessment and evaluation.
    Nordling J; Nielsen K
    Arch Esp Urol; 1994 Nov; 47(9):838-46. PubMed ID: 7530939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variability of pressure-flow analysis parameters in repeated cystometry in patients with benign prostatic hyperplasia.
    Rosier PF; de la Rosette JJ; Koldewijn EL; Debruyne FM; Wijkstra H
    J Urol; 1995 May; 153(5):1520-5. PubMed ID: 7536260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Relaxing effect of nicergoline on the female urethra in peripheral neurogenic vesicosphincter dysfunctions].
    Galas JM; Grillot MJ; Vasse MG; Vaillandet M; Guillemin P
    J Urol (Paris); 1984; 90(8-9):563-5. PubMed ID: 6398829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Age and bladder outlet obstruction are independently associated with detrusor overactivity in patients with benign prostatic hyperplasia.
    Oelke M; Baard J; Wijkstra H; de la Rosette JJ; Jonas U; Höfner K
    Eur Urol; 2008 Aug; 54(2):419-26. PubMed ID: 18325657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Quantitative EEG examinations on the vigilance stabilizing effect of nicergoline / Results of a double blind study with gerontopsychiatric patients (author's transl)].
    Bente D; Glatthaar G; Ulrich G; Lewinsky M
    Arzneimittelforschung; 1979; 29(11):1804-8. PubMed ID: 543890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenoxybenzamine reduces bladder outlet obstruction in benign prostatic hyperplasia. A urodynamic investigation.
    Gerstenberg T; Blaabjerg J; Nielsen ML; Clausen S
    Invest Urol; 1980 Jul; 18(1):29-31. PubMed ID: 6157651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Controlled study with nicergoline and placebo in cerebral and peripheral vascular insufficiency in the aged].
    Cascone A; Liverta C; Pollini C
    Minerva Cardioangiol; 1978; 26(1-2):95-100. PubMed ID: 347330
    [No Abstract]   [Full Text] [Related]  

  • 15. Influence of bladder outlet obstruction and detrusor contractility on residual urine in patients with benign prostatic hyperplasia.
    Zhang P; Wu Z; Gao J
    Chin Med J (Engl); 2003 Oct; 116(10):1508-10. PubMed ID: 14570611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Noninvasive assessment of prostatic obstruction in elderly men with lower urinary tract symptoms associated with benign prostatic hyperplasia.
    van Venrooij GE; Eckhardt MD; Boon TA
    Urology; 2004 Mar; 63(3):476-80. PubMed ID: 15028441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The doxazosin treatment of the changes in the bladder filling phase in benign prostatic hyperplasia].
    Salinas Casado J; Esteban Fuertes M; Virseda Chamorro M; Ramírez Fernández JC; Salomón Moh'd S; Luengo Alpuente S; Resel Estévez L
    Arch Esp Urol; 1997 Oct; 50(8):840-5. PubMed ID: 9463281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Analysis of the diagnostic criteria of bladder outlet obstruction in benign prostatic hyperplasia].
    Shuang W; Wang D; Zhang X; Liu C; Cao X; Wang J; Gao J; Ren Z; Lü Y
    Zhonghua Nan Ke Xue; 2004 Oct; 10(10):743-6. PubMed ID: 15562786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional outcome following photoselective vaporisation of the prostate (PVP): urodynamic findings within 12 months follow-up.
    Hamann MF; Naumann CM; Seif C; van der Horst C; Jünemann KP; Braun PM
    Eur Urol; 2008 Oct; 54(4):902-7. PubMed ID: 18502565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostate botulinum A toxin injection--an alternative treatment for benign prostatic obstruction in poor surgical candidates.
    Kuo HC
    Urology; 2005 Apr; 65(4):670-4. PubMed ID: 15833506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.